US biotechnology major

Two large phase-3 trials of Novavax's COVID-19 vaccine show high levels of protection against infection: research head

US biotechnology major Novavax on Wednesday said two large phase-3 trials of its COVID-19 vaccine being manufactured by Pune-based Serum Institute of India have shown that the